Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2012

Open Access 01-12-2012 | Research

Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells

Authors: Bing Liang, Dejuan Kong, Yang Liu, Nan Liang, Mengzi He, Shumei Ma, Xiaodong Liu

Published in: Radiation Oncology | Issue 1/2012

Login to get access

Abstract

Purpose

Autophagy has attracted attentions as a novel mechanism for tumor development. In this study Human ovarian carcinoma cell line SKOV3 and multidrug-resistant phenotype SKVCR cells were used and the roles of autophagy in radiation-induced cell death were analyzed.

Methods and materials

Cell viability was examined by colony formation and cell counting kit-8 (CCK-8) assay, 3MA and ZVAD were used to block autophagy and apoptosis, respectively. Quantitative real-time PCR was used to detect mRNA level and Western blot was used to detect protein expression, monodansylcadaverine (MDC) staining and flow cytometery were used for autophagy, apoptosis and cell cycle dynamics, respectively.

Results

(1) The radiosensitivity exhibited differently in SKOV3 and SKVCR cells (SKOV3: D0=3.37, SKVCR: D0= 4.18); compared with SKOV3 the constitutive expression of MAPLC3 in SKVCR was higher, but no change of Caspase-3 and cleaved Caspase-3. (2) The ionizing radiation (IR)- induced apoptosis and autophagy were significant in both cells (P<0.05); inhibition of apoptosis with ZVAD showed no impact on survival of SKOV3 and SKVCR cells after radiation, while inhibition of autophagy significantly decreased viability in SKVCR cells, for SKVO3 cells only low level of radiation (2 Gy and 4 Gy) could decrease the viability(P<0.05). (3) ZVAD inhibited apoptosis and autophagy in both cells, 3MA inhibit apoptosis in SKOV3, and promote apoptosis in SKVCR, together with inhibition of autophagy. (4) G2/M arrest was induced by radiation in both cells; the accumulation of G2/M was more significant in SKOV3, 3MA attenuated the radiation-induced S phase delay in SKVCR.

Conclusion

IR-induced autophagy provides a self-protective mechanism against radiotherapy in SKVCR cells, the use of autophagy inhibitor, 3MA, increases the killing effects of radiation by inhibiting autophagy and radiation- induced S phase delay, also by the increase of apoptosis, which suggests a better therapeutic strategy in drug- resistant SKVCR ovarian cancer cells.
Appendix
Available only for authorised users
Literature
1.
Siegel R, Ward E, Brawley O, Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61: 212-236. 10.3322/caac.20121CrossRefPubMed
2.
Gao Y, Liu Z, Chen X, Luo W, Zhang L, Wang J: Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study. BMC Cancer 2011, 11: 439. 10.1186/1471-2407-11-439CrossRefPubMed
3.
Jin Z, El-Deiry WS: Overview of cell death signaling pathways. Cancer Biol Ther 2005, 4: 139-163. 10.4161/cbt.4.2.1508CrossRefPubMed
4.
Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW: A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002, 109: 335-346. 10.1016/S0092-8674(02)00734-1CrossRefPubMed
5.
Chu K, Teele N, Dewey MW, Albright N, Dewey WC: Computerized video time lapse study of cell cycle delay and arrest, mitotic catastrophe, apoptosis and clonogenic survival in irradiated 14-3-3sigma and CDKN1A (p21) knockout cell lines. Radiat Res 2004, 162: 270-286. 10.1667/RR3221CrossRefPubMed
6.
Roninson IB, Broude EV, Chang BD: If not apoptosis, then what? treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001, 4: 303-313. 10.1054/drup.2001.0213CrossRefPubMed
7.
Kondo Y, Kanzawa T, Sawaya R, Kondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005, 5: 726-734. 10.1038/nrc1692CrossRefPubMed
8.
Yu JH, Cui Q, Jiang YY, Yang W, Tashiro S, Onodera S, Ikejima T: Pseudolaric acid B induces apoptosis, senescence, and mitotic arrest in human breast cancer MCF-7. Acta Pharmacol Sin 2007, 28: 1975-1983. 10.1111/j.1745-7254.2007.00706.xCrossRefPubMed
9.
Verheij M, Bartelink H: Radiation-induced apoptosis. Cell Tissue Res 2000, 301: 133-142. 10.1007/s004410000188CrossRefPubMed
10.
Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D, Yahalom J: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001, 61: 439-444.PubMed
11.
Talloczy Z, Jiang W, Virgin HW, Leib DA, Scheuner D, Kaufman RJ, Eskelinen EL, Levine B: Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci USA 2002, 99: 190-195. 10.1073/pnas.012485299CrossRefPubMed
12.
Klionsky DJ, Emr SD: Autophagy as a regulated pathway of cellular degradation. Science 2000, 290: 1717-1721.CrossRefPubMed
13.
Martinet W, De Meyer GR, Andries L, Herman AG, Kockx MM: In situ detection of starvation-induced autophagy. J Histochem Cytochem 2006, 54: 85-96. 10.1369/jhc.5A6743.2005CrossRefPubMed
14.
Rouschop KM, Ramaekers CH, Schaaf MB, Keulers TG, Savelkouls KG, Lambin P, Koritzinsky M, Wouters BG: Autophagy is required during cycling hypoxia to lower production of reactive oxygen species. Radiother Oncol 2009, 92: 411-416. 10.1016/j.radonc.2009.06.029CrossRefPubMed
15.
Pursiheimo JP, Rantanen K, Heikkinen PT, Johansen T, Jaakkola PM: Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene 2009, 28: 334-344. 10.1038/onc.2008.392CrossRefPubMed
16.
Papandreou I, Lim AL, Laderoute K, Denko NC: Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death Differ 2008, 15: 1572-1581. 10.1038/cdd.2008.84CrossRefPubMed
17.
Suhy DA, Giddings TH Jr, Kirkegaard K: Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol 2000, 74: 8953-8965. 10.1128/JVI.74.19.8953-8965.2000CrossRefPubMed
18.
19.
Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ: Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304: 1500-1502. 10.1126/science.1096645CrossRefPubMed
20.
Leminen A, Auranen A, Butzow R, Hietanen S, Komulainen M, Kuoppala T, Maenpaa J, Puistola U, Vuento M, Vuorela P, Yliskoski M: [Update on current care guidelines: ovarian cancer]. Duodecim 2012, 128: 1300-1301.PubMed
21.
22.
Firat S, Erickson B: Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. Gynecol Oncol 2001, 80: 213-220. 10.1006/gyno.2000.6059CrossRefPubMed
23.
Tinger A, Waldron T, Peluso N, Katin MJ, Dosoretz DE, Blitzer PH, Rubenstein JH, Garton GR, Nakfoor BA, Patrice SJ, et al.: Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma. Int J Radiat Oncol Biol Phys 2001, 51: 1256-1263. 10.1016/S0360-3016(01)01733-3CrossRefPubMed
24.
Fujiwara K, Suzuki S, Yoden E, Ishikawa H, Imajo Y, Kohno I: Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy. Int J Gynecol Cancer 2002, 12: 250-256. 10.1046/j.1525-1438.2002.01096.xCrossRefPubMed
25.
May LF, Belinson JL, Roland TA: Palliative benefit of radiation therapy in advanced ovarian cancer. Gynecol Oncol 1990, 37: 408-411. 10.1016/0090-8258(90)90377-WCrossRefPubMed
26.
Corn BW, Lanciano RM, Boente M, Hunter WM, Ladazack J, Ozols RF: Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure. Cancer 1994, 74: 2979-2983. 10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-BCrossRefPubMed
27.
Kong D, Ma S, Liang B, Yi H, Zhao Y, Xin R, Cui L, Jia L, Liu X: The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells. Biomed Pharmacother 2012, 66: 271-278.CrossRefPubMed
28.
Zubova SG, Danilov AO, Myshkov AI, Bykova TV, Zaritskii A, Okulov VB: [The MDR gene and cellular sensitivity to various effects]. Vopr Onkol 2000, 46: 199-201.PubMed
29.
Wei R, Zhang Y, Shen L, Jiang W, Li C, Zhong M, Xie Y, Yang D, He L, Zhou Q: Comparative proteomic and radiobiological analyses in human lung adenocarcinoma cells. Mol Cell Biochem 2012, 359: 151-159. 10.1007/s11010-011-1008-xCrossRefPubMed
30.
Meyn RE, Milas L, Ang KK: The role of apoptosis in radiation oncology. Int J Radiat Biol 2009, 85: 107-115. 10.1080/09553000802662595CrossRefPubMed
31.
Sen S, D’Incalci M: Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett 1992, 307: 122-127. 10.1016/0014-5793(92)80914-3CrossRefPubMed
32.
Fujiwara K, Iwado E, Mills GB, Sawaya R, Kondo S, Kondo Y: Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy. Int J Oncol 2007, 31: 753-760.PubMed
33.
Kim R, Emi M, Tanabe K, Uchida Y, Arihiro K: The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment. Eur J Surg Oncol 2006, 32: 269-277. 10.1016/j.ejso.2005.12.006CrossRefPubMed
34.
Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB: Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005, 120: 237-248. 10.1016/j.cell.2004.11.046CrossRefPubMed
35.
Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, Chen G, Jin S, White E: Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007, 21: 1367-1381. 10.1101/gad.1545107CrossRefPubMed
36.
Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A: Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007, 14: 500-510. 10.1038/sj.cdd.4402039CrossRefPubMed
37.
Jin S, DiPaola RS, Mathew R, White E: Metabolic catastrophe as a means to cancer cell death. J Cell Sci 2007, 120: 379-383. 10.1242/jcs.03349CrossRefPubMed
38.
Moretti L, Cha YI, Niermann KJ, Lu B: Switch between apoptosis and autophagy: radiation-induced endoplasmic reticulum stress? Cell Cycle 2007, 6: 793-798. 10.4161/cc.6.7.4036CrossRefPubMed
39.
Maiuri MC, Zalckvar E, Kimchi A, Kroemer G: Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007, 8: 741-752. 10.1038/nrm2239CrossRefPubMed
40.
Cui Q, Tashiro S, Onodera S, Minami M, Ikejima T: Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells. Biol Pharm Bull 2007, 30: 859-864. 10.1248/bpb.30.859CrossRefPubMed
41.
Gozuacik D, Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23: 2891-2906. 10.1038/sj.onc.1207521CrossRefPubMed
42.
Wu YT, Tan HL, Huang Q, Kim YS, Pan N, Ong WY, Liu ZG, Ong CN, Shen HM: Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy 2008, 4: 457-466.CrossRefPubMed
43.
Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H: Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 2009, 16: 761-771. 10.1245/s10434-008-0260-0CrossRefPubMed
44.
Bergonie J, Tribondeau L: Interpretation of some results of radiotherapy and an attempt at determining a logical technique of treatment. Radiat Res 1959, 11: 587-588. 10.2307/3570812CrossRefPubMed
45.
Ge JN, Huang D, Xiao T, Wang Z, Li XL, Xiao H, Tao DD, Gong JP: [Effect of starvation-induced autophagy on cell cycle of tumor cells]. Ai Zheng 2008, 27: 788-794.PubMed
Metadata
Title
Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells
Authors
Bing Liang
Dejuan Kong
Yang Liu
Nan Liang
Mengzi He
Shumei Ma
Xiaodong Liu
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2012
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-7-213

Other articles of this Issue 1/2012

Radiation Oncology 1/2012 Go to the issue

Research

Hypofractionated image-guided breath-hold SABR (Stereotactic Ablative Body Radiotherapy) of liver metastases – clinical results

Research

Four-dimensional measurement of the displacement of metal clips or postoperative surgical staples during 320-multislice computed tomography scanning of gastric cancer

Research

Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study

Research

A comparison of radiographic techniques and electromagnetic transponders for localization of the prostate

Research

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

Research

Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework